A batch of medical institutions that illegally used traditional Chinese medicine injections were severely punished by the Medical Insurance Bureau
Time of Update: 2022-01-26
In addition, medical institutions that use traditional Chinese medicine injections that are restricted to second-level hospitals and above due to violations include:Suichuan County Dayen Town Central Health Center and Dakeng Township Health Center illegally used Xiangdan injection, Qingkailing injection, Shengmai injection, etc.
Beite Pharmaceuticals is the first to submit a 4-class generic application for Dacomitinib, Pfizer's new products soared by 200
Time of Update: 2022-01-22
Figure 1: The latest product status of Bite Pharmaceuticals Source: Pfizer’s dacomitinib tablets were officially approved for marketing in China in May 2019, and can be used as a single drug for epidermal growth factor receptor (EGFR) No.
Figure 2: Sales of Pfizer’s dacomitinib tablets in the retail market (unit: 100 million yuan) Source: Minet.
Health care regulation will be strengthened again! The first Fund Supervision Bill was passed
Time of Update: 2020-12-24
The Regulations (Draft) adhere to the people's health as the center, determine the rights and responsibilities of the medical insurance departments, designated medical institutions, insured persons, etc., and stipulate that, in accordance with the principle of the people, strengthen medical security services, timely settlement and allocation of medical insurance funds, and improve the quality of service.
The "three-year action" to alleviate poverty in health care is about to close, benefiting more than 460 million poor people and reducing the cumulative burden by nearly
Time of Update: 2020-10-22
Chen Jinfu, a member of the Party Group of the National Health Insurance Administration and deputy director of the National Health Insurance Administration, said that since 2018, the health care poverty alleviation policy has benefited more than 460 million people in poverty and helped the poor reduce their burden by nearly 300 billion yuan.
A province has not been evaluated generic drug price reduction knife medical insurance payment standards to develop a great new idea
Time of Update: 2020-09-28
This program is slightly different from other provinces, take the price of generic drugs without evaluation, in the medical insurance payment standards developed quite profound: the original research, evaluation and other products within three years to the generic drug winning varieties close.
30 drugs are monitored
Time of Update: 2020-06-19
according to the information gathered from Nanyang Pharmaceutical Co., Ltd., recently, Wuhan Pharmaceutical Machinery Co., Ltd issued the notice on soliciting public opinions on the
The first DAA was officially listed in China today, and the battle to "cure hepatitis C" is fully launched
Time of Update: 2017-07-27
Source: e drug manager 2017-07-27 global hepatitis C drug market has experienced a process of "rapid outbreak, rapid saturation and sharp contraction" in recent three years, which determines the great